Star-Shaped Polymers Kill Antibiotic Resistant Bacteria
|
By HospiMedica International staff writers Posted on 05 Oct 2016 |

Image: A bacteria cell before (L) and after treatment (R) with star-shaped polymers (Photo courtesy of UNIMELB).
A new study suggests that structurally nanoengineered antimicrobial peptide polymers (SNAPPs) could provide a low-cost and effective antimicrobial agent against multidrug resistant (MDR) bacteria.
Developed by researchers at the University of Melbourne (UNIMELB; Parkville, Australia), the star-shaped SNAPP is extremely effective at killing Gram-negative bacteria while being non-toxic to the body’s own cells, thanks to its unique antimicrobial activity. SNAPPs induce cell death by a multimodal mechanism that combines outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane, and induction of the apoptotic-like death pathway.
The SNAPPs exhibited sub-μM activity against all Gram-negative bacteria tested, including the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter) pathogens and other colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. In addition, the researchers did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. The study was published on September 12, 2016, in Nature Microbiology.
“It is estimated that the rise of superbugs will cause up to ten million deaths a year by 2050. In addition, there have only been one or two new antibiotics developed in the last 30 years,” concluded senior author Professor Greg Qiao, PhD, of the department of chemical and biomolecular engineering, and colleagues. “Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents, and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.”
Antimicrobial polymers are engineered to mimic peptides used by the immune systems of living things to kill bacteria. Typically, they are produced by attaching or inserting an active antimicrobial agent onto a polymer backbone via an alkyl or acetyl linker. The use of antimicrobial polymers may enhance the efficiency and selectivity of common antimicrobial agents, while decreasing associated environmental hazards since they are generally nonvolatile and chemically stable.
Related Links:
University of Melbourne
Developed by researchers at the University of Melbourne (UNIMELB; Parkville, Australia), the star-shaped SNAPP is extremely effective at killing Gram-negative bacteria while being non-toxic to the body’s own cells, thanks to its unique antimicrobial activity. SNAPPs induce cell death by a multimodal mechanism that combines outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane, and induction of the apoptotic-like death pathway.
The SNAPPs exhibited sub-μM activity against all Gram-negative bacteria tested, including the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter) pathogens and other colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. In addition, the researchers did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. The study was published on September 12, 2016, in Nature Microbiology.
“It is estimated that the rise of superbugs will cause up to ten million deaths a year by 2050. In addition, there have only been one or two new antibiotics developed in the last 30 years,” concluded senior author Professor Greg Qiao, PhD, of the department of chemical and biomolecular engineering, and colleagues. “Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents, and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.”
Antimicrobial polymers are engineered to mimic peptides used by the immune systems of living things to kill bacteria. Typically, they are produced by attaching or inserting an active antimicrobial agent onto a polymer backbone via an alkyl or acetyl linker. The use of antimicrobial polymers may enhance the efficiency and selectivity of common antimicrobial agents, while decreasing associated environmental hazards since they are generally nonvolatile and chemically stable.
Related Links:
University of Melbourne
Latest Critical Care News
- Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring
- Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
- Finger Cuff Algorithm Enables Noninvasive Screening for Aortic Stenosis
- Vibration-Based Tools Aim to Improve Newborn Screening for Heart Defects
- Dried Platelet Biologic Reduces Hemorrhage After Traumatic Brain Injury
- Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
- AI Expands Across Heart Failure Care Continuum to Improve Management
- Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
- Microneedle Sensor Enables Continuous Monitoring of Drug Clearance
- 3D Brain Imaging Marker Predicts Surgical Outcomes in Dementia-Causing Hydrocephalus
- Printed Artificial Neurons Stimulate Natural Brain Circuits
- Review Advances Precision Care Pathway for Meningioma Management
- Synthetic Biology Approach Enables On-Demand Liver Tissue Growth
- Bioinspired Imaging System Identifies Cancerous Lymph Nodes Intraoperatively
- Portable AI Device Enables Low-Cost Screening for Anterior Eye Diseases
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreSurgical Techniques
view channel
Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes
Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions
Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Transcatheter Venous Arterialization Improves Outcomes in No-Option Limb Ischemia Patients
Chronic limb-threatening ischemia (CLTI) is an advanced stage of peripheral artery disease in which plaque narrows leg arteries and severely restricts blood flow, leading to pain, nonhealing wounds, and... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channelBusiness
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more







